Engineering Chinese hamster ovary cells to maximize effector function of produced antibodies using FUT8 siRNA

被引:129
作者
Mori, K [1 ]
Kuni-Karnochi, R [1 ]
Yamane-Ohnuki, N [1 ]
Wakitani, M [1 ]
Yamano, K [1 ]
Imai, H [1 ]
Kanda, Y [1 ]
Niwa, R [1 ]
Iida, S [1 ]
Uchida, K [1 ]
Shitara, K [1 ]
Satoh, M [1 ]
机构
[1] Kyowa Hakko Kogyo Co Ltd, Tokyo Res Labs, 3-6-6 Asahimachi, Machida, Tokyo 1948533, Japan
关键词
recombinant antibody production; antibody-dependent cellular cytotoxicity; siRNA; alpha 1,6 fucosyltransferase; fed-batch culture; CHO cells;
D O I
10.1002/bit.20326
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We explored the possibility of converting established antibody-producing cells to cells producing high anti body-dependent cellular cytotoxicity (ADCC) antibodies. The conversion was made by constitutive expression of small interfering RNA (siRNA) against alpha1,6 fucosyltransferase (FUT8). We found two effective siRNAs, which reduce FUT8 mRNA expression to 20% when introduced into Chinese hamster ovary (CHO)/DG44 cells. Selection for Lens culinaris agglutinin (LCA)-resistant clones after introduction of the FUT8 siRNA expression plasmids yields clones producing highly defucosylated (approximate to 60%) antibody with over 100-fold higher ADCC compared to antibody produced by the parental cells (approximate to 10% defucosylated). Moreover, the selected clones remain stable, producing defucosylated antibody even in serum-free fed-batch culture. Our results demonstrate that constitutive FUT8 siRNA expression can control the oligosaccharide structure of recombinant antibody produced by CHO cells to yield antibodies with dramatically enhanced ADCC. (C) 2004 Wiley Periodicals, Inc.
引用
收藏
页码:901 / 908
页数:8
相关论文
共 33 条
[1]   Hammerhead ribozyme design and application [J].
Amarzguioui, M ;
Prydz, H .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1998, 54 (11) :1175-1202
[2]  
BENNETT CF, 1999, BIOCHIM BIOPHYS ACTA, V1489, P9
[3]   A system for stable expression of short interfering RNAs in mammalian cells [J].
Brummelkamp, TR ;
Bernards, R ;
Agami, R .
SCIENCE, 2002, 296 (5567) :550-553
[4]   Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene [J].
Cartron, G ;
Dacheux, L ;
Salles, G ;
Solal-Celigny, P ;
Bardos, P ;
Colombat, P ;
Watier, H .
BLOOD, 2002, 99 (03) :754-758
[5]   Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets [J].
Clynes, RA ;
Towers, TL ;
Presta, LG ;
Ravetch, JV .
NATURE MEDICINE, 2000, 6 (04) :443-446
[6]   Expression of GnTIII in a recombinant anti-CD20 CHO production cell line:: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FcγRIII [J].
Davies, J ;
Jiang, LY ;
Pan, LZ ;
LaBarre, MJ ;
Anderson, D ;
Reff, M .
BIOTECHNOLOGY AND BIOENGINEERING, 2001, 74 (04) :288-294
[7]   Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells [J].
Elbashir, SM ;
Harborth, J ;
Lendeckel, W ;
Yalcin, A ;
Weber, K ;
Tuschl, T .
NATURE, 2001, 411 (6836) :494-498
[8]  
Harborth J, 2001, J CELL SCI, V114, P4557
[9]   Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor [J].
Holen, T ;
Amarzguioui, M ;
Wiiger, MT ;
Babaie, E ;
Prydz, H .
NUCLEIC ACIDS RESEARCH, 2002, 30 (08) :1757-1766
[10]   Expression profiling reveals off-target gene regulation by RNAi [J].
Jackson, AL ;
Bartz, SR ;
Schelter, J ;
Kobayashi, SV ;
Burchard, J ;
Mao, M ;
Li, B ;
Cavet, G ;
Linsley, PS .
NATURE BIOTECHNOLOGY, 2003, 21 (06) :635-637